Mrs. Brenda Ann Dacosta

NP | Nurse Practitioner

Mrs. Brenda Ann Dacosta is a Los Angeles, California based nurse practitioner. Her current practice location is 5850 S Main St, Los Angeles. Patients can reach her at 323-846-4265 or can fax her at 323-232-8115. Mrs. Brenda Ann Dacosta is NP and her NPI number (Unique professional ID assigned by NPPES) is 1063567345.
Mrs. Brenda Ann Dacosta has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.

Complete Profile:
Mrs. Brenda Ann Dacosta speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.
Name: Mrs. Brenda Ann Dacosta
Specialization: Nurse Practitioner (NP)
Gender:Female
Credentials: NP
Practice Address:5850 S Main St, Los Angeles,
California, 90003-1215
Phone:323-846-4265
Fax:323-232-8115
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1063567345
NPI Enumeration Date: 24 Jan, 2007
NPI Last Update On: 08 Jul, 2007

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: Mrs. Brenda Ann Dacosta
490 Pine Ave Apt 408-p,
Long Beach, California
Zip: 90802-2386
Phone Number: 562-432-0410
Patients can reach Mrs. Brenda Ann Dacosta at 5850 S Main St, Los Angeles, California or can call to book an appointment on 323-846-4265.
Comments/ Reviews:

Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 September, 2024.